Invention Grant
- Patent Title: Methods of treating Fabry patients having renal impairment
-
Application No.: US17670095Application Date: 2022-02-11
-
Publication No.: US11376244B2Publication Date: 2022-07-05
- Inventor: Jeff Castelli , Elfrida Benjamin
- Applicant: Amicus Therapeutics, Inc.
- Applicant Address: US PA Philadelphia
- Assignee: Amicus Therapeutics, Inc.
- Current Assignee: Amicus Therapeutics, Inc.
- Current Assignee Address: US PA Philadelphia
- Agency: Servilla Whitney LLC
- Main IPC: A61K31/445
- IPC: A61K31/445 ; A61K38/16 ; A61P13/12 ; A61K9/48
Abstract:
Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in α-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.
Public/Granted literature
- US20220168289A1 Methods Of Treating Fabry Patients Having Renal Impairment Public/Granted day:2022-06-02
Information query
IPC分类:
